Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway

Fig. 2

New analogs of the C3 inhibitor compstatin (CP40-KK) could bind not only human C3 but also rat C3 A Representative sensorgram showing the binding of CP40-KK to immobilized human C3 and rat C3. B The ELISA based approach showed the direct binding of rat C3 and CP40-KK. C, D The CH50 test (Mayer method) was applied to measure rat complement C3 function. E The tail bleeding time was measured in four groups. Multiple comparisons made by one-way ANOVA; *P < 0.05,  **P < 0.01

Back to article page